Drug intelligence / Profile preview

Taiqi Peiyuan Mianjian Keli

Development stage
Unknown
Lead developer
Affiliated Hospital of Gansu University of Chinese Medicine
Administration
Oral
01

Overview

Taiqi Peiyuan Mianjian Keli is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Affiliated Hospital of Gansu University of Chinese Medicine. Formulated as instant granules that do not require traditional decoction, it is primarily indicated for the treatment of leukopenia, particularly myelosuppression induced by chemotherapy or radiotherapy in cancer patients. The preparation is composed of several botanical extracts, including *Pseudostellaria heterophylla* (Taizishen) and *Astragalus membranaceus* (Huangqi), which are traditionally used to tonify qi, nourish the blood, and strengthen the body's 'original foundation' (Peiyuan). Clinical application focuses on stimulating hematopoiesis and modulating immune function to restore white blood cell counts and improve the quality of life in immunocompromised patients.

Brand names
Taiqi Peiyuan Mianjian Keli
Other names
太芪培元免煎颗粒Taiqi Peiyuan Keli太芪培元颗粒

Beyond the preview

Go deeper on Taiqi Peiyuan Mianjian Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiqi Peiyuan Mianjian Keli.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call